ロミプロスチムの世界市場 2020年

• 英文タイトル：Global Romiplostim Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115061 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、ロミプロスチムの世界市場を調査対象にし、ロミプロスチムの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（250μg/0.5mL、500μg/1mL）、用途別分析（成人、小児患者）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：AMGEN ・企業別売上、市場シェア ・ロミプロスチムの地域別市場分析 ・ロミプロスチムの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ロミプロスチムのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ロミプロスチムのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ロミプロスチムの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ロミプロスチムの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ロミプロスチムの種類別市場規模2015-2020：250μg/0.5mL、500μg/1mL ・ロミプロスチムの用途別市場規模2015-2020：成人、小児患者 ・ロミプロスチムの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Romiplostim market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Romiplostim market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Romiplostim market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Romiplostim market has been segmented into:
250 μg/0.5 mL
500 μg/1 mL

By Application, Romiplostim has been segmented into:
Adults
Pediatric patients

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Romiplostim market presented in the report. This section sheds light on the sales growth of different regional and country-level Romiplostim markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Romiplostim market.

The report offers in-depth assessment of the growth and other aspects of the Romiplostim market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Romiplostim Market Share Analysis
Romiplostim competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Romiplostim sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Romiplostim sales, revenue and market share for each player covered in this report.

The major players covered in Romiplostim are:
AMGEN

レポート目次

---

1 Romiplostim Market Overview
1.1 Product Overview and Scope of Romiplostim
1.2 Classification of Romiplostim by Type
1.2.1 Global Romiplostim Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Romiplostim Revenue Market Share by Type in 2019
1.2.3 250 μg/0.5 mL
1.2.4 500 μg/1 mL
1.3 Global Romiplostim Market by Application
1.3.1 Overview: Global Romiplostim Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adults
1.3.3 Pediatric patients
1.4 Global Romiplostim Market by Regions
1.4.1 Global Romiplostim Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Romiplostim (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Romiplostim Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Romiplostim Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Romiplostim Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Romiplostim Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Romiplostim Status and Prospect (2015-2025)
2 Company Profiles
2.1 AMGEN
2.1.1 AMGEN Details
2.1.2 AMGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AMGEN SWOT Analysis
2.1.4 AMGEN Product and Services
2.1.5 AMGEN Romiplostim Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Romiplostim Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Romiplostim Players Market Share
3.2.2 Top 10 Romiplostim Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Romiplostim Revenue and Market Share by Regions
4.2 North America Romiplostim Revenue and Growth Rate (2015-2020)
4.3 Europe Romiplostim Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Romiplostim Revenue and Growth Rate (2015-2020)
4.5 South America Romiplostim Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Romiplostim Revenue and Growth Rate (2015-2020)
5 North America Romiplostim Revenue by Countries
5.1 North America Romiplostim Revenue by Countries (2015-2020)
5.2 USA Romiplostim Revenue and Growth Rate (2015-2020)
5.3 Canada Romiplostim Revenue and Growth Rate (2015-2020)
5.4 Mexico Romiplostim Revenue and Growth Rate (2015-2020)
6 Europe Romiplostim Revenue by Countries
6.1 Europe Romiplostim Revenue by Countries (2015-2020)
6.2 Germany Romiplostim Revenue and Growth Rate (2015-2020)
6.3 UK Romiplostim Revenue and Growth Rate (2015-2020)
6.4 France Romiplostim Revenue and Growth Rate (2015-2020)
6.5 Russia Romiplostim Revenue and Growth Rate (2015-2020)
6.6 Italy Romiplostim Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Romiplostim Revenue by Countries
7.1 Asia-Pacific Romiplostim Revenue by Countries (2015-2020)
7.2 China Romiplostim Revenue and Growth Rate (2015-2020)
7.3 Japan Romiplostim Revenue and Growth Rate (2015-2020)
7.4 Korea Romiplostim Revenue and Growth Rate (2015-2020)
7.5 India Romiplostim Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Romiplostim Revenue and Growth Rate (2015-2020)
8 South America Romiplostim Revenue by Countries
8.1 South America Romiplostim Revenue by Countries (2015-2020)
8.2 Brazil Romiplostim Revenue and Growth Rate (2015-2020)
8.3 Argentina Romiplostim Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Romiplostim by Countries
9.1 Middle East & Africa Romiplostim Revenue by Countries (2015-2020)
9.2 Saudi Arabia Romiplostim Revenue and Growth Rate (2015-2020)
9.3 UAE Romiplostim Revenue and Growth Rate (2015-2020)
9.4 Egypt Romiplostim Revenue and Growth Rate (2015-2020)
9.5 South Africa Romiplostim Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Romiplostim Revenue and Market Share by Type (2015-2020)
10.2 Global Romiplostim Market Forecast by Type (2019-2024)
10.3 250 μg/0.5 mL Revenue Growth Rate (2015-2025)
10.4 500 μg/1 mL Revenue Growth Rate (2015-2025)
11 Global Romiplostim Market Segment by Application
11.1 Global Romiplostim Revenue Market Share by Application (2015-2020)
11.2 Romiplostim Market Forecast by Application (2019-2024)
11.3 Adults Revenue Growth (2015-2020)
11.4 Pediatric patients Revenue Growth (2015-2020)
12 Global Romiplostim Market Size Forecast (2021-2025)
12.1 Global Romiplostim Market Size Forecast (2021-2025)
12.2 Global Romiplostim Market Forecast by Regions (2021-2025)
12.3 North America Romiplostim Revenue Market Forecast (2021-2025)
12.4 Europe Romiplostim Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Romiplostim Revenue Market Forecast (2021-2025)
12.6 South America Romiplostim Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Romiplostim Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Romiplostim Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Romiplostim by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Romiplostim Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Romiplostim Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AMGEN Corporate Information, Location and Competitors
Table 6. AMGEN Romiplostim Major Business
Table 7. AMGEN Romiplostim Total Revenue (USD Million) (2017-2018)
Table 8. AMGEN SWOT Analysis
Table 9. AMGEN Romiplostim Product and Solutions
Table 10. AMGEN Romiplostim Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Global Romiplostim Revenue (Million USD) by Players (2015-2020)
Table 12. Global Romiplostim Revenue Share by Players (2015-2020)
Table 13. Global Romiplostim Revenue (Million USD) by Regions (2015-2020)
Table 14. Global Romiplostim Revenue Market Share by Regions (2015-2020)
Table 15. North America Romiplostim Revenue by Countries (2015-2020)
Table 16. North America Romiplostim Revenue Market Share by Countries (2015-2020)
Table 17. Europe Romiplostim Revenue (Million USD) by Countries (2015-2020)
Table 18. Asia-Pacific Romiplostim Revenue (Million USD) by Countries (2015-2020)
Table 19. South America Romiplostim Revenue by Countries (2015-2020)
Table 20. South America Romiplostim Revenue Market Share by Countries (2015-2020)
Table 21. Middle East and Africa Romiplostim Revenue (Million USD) by Countries (2015-2020)
Table 22. Middle East and Africa Romiplostim Revenue Market Share by Countries (2015-2020)
Table 23. Global Romiplostim Revenue (Million USD) by Type (2015-2020)
Table 24. Global Romiplostim Revenue Share by Type (2015-2020)
Table 25. Global Romiplostim Revenue Forecast by Type (2021-2025)
Table 26. Global Romiplostim Revenue by Application (2015-2020)
Table 27. Global Romiplostim Revenue Share by Application (2015-2020)
Table 28. Global Romiplostim Revenue Forecast by Application (2021-2025)
Table 29. Global Romiplostim Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Romiplostim Picture
Figure 2. Global Romiplostim Revenue Market Share by Type in 2019
Figure 3. 250 μg/0.5 mL Picture
Figure 4. 500 μg/1 mL Picture
Figure 5. Romiplostim Revenue Market Share by Application in 2019
Figure 6. Adults Picture
Figure 7. Pediatric patients Picture
Figure 8. Global Romiplostim Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Romiplostim Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Romiplostim Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Romiplostim Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Romiplostim Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Romiplostim Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Romiplostim Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Romiplostim Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Romiplostim Revenue Market Share in 2019
Figure 17. Global Top 10 Players Romiplostim Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Romiplostim Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Romiplostim Revenue Market Share by Regions (2015-2020)
Figure 21. Global Romiplostim Revenue Market Share by Regions in 2018
Figure 22. North America Romiplostim Revenue and Growth Rate (2015-2020)
Figure 23. Europe Romiplostim Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Romiplostim Revenue and Growth Rate (2015-2020)
Figure 25. South America Romiplostim Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Romiplostim Revenue and Growth Rate (2015-2020)
Figure 27. North America Romiplostim Revenue Market Share by Countries (2015-2020)
Figure 28. North America Romiplostim Revenue Market Share by Countries in 2019
Figure 29. USA Romiplostim Revenue and Growth Rate (2015-2020)
Figure 30. Canada Romiplostim Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Romiplostim Revenue and Growth Rate (2015-2020)
Figure 32. Europe Romiplostim Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Romiplostim Revenue Market Share by Countries in 2019
Figure 34. Germany Romiplostim Revenue and Growth Rate (2015-2020)
Figure 35. UK Romiplostim Revenue and Growth Rate (2015-2020)
Figure 36. France Romiplostim Revenue and Growth Rate (2015-2020)
Figure 37. Russia Romiplostim Revenue and Growth Rate (2015-2020)
Figure 38. Italy Romiplostim Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Romiplostim Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Romiplostim Revenue Market Share by Countries in 2019
Figure 41. China Romiplostim Revenue and Growth Rate (2015-2020)
Figure 42. Japan Romiplostim Revenue and Growth Rate (2015-2020)
Figure 43. Korea Romiplostim Revenue and Growth Rate (2015-2020)
Figure 44. India Romiplostim Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Romiplostim Revenue and Growth Rate (2015-2020)
Figure 46. South America Romiplostim Revenue Market Share by Countries (2015-2020)
Figure 47. South America Romiplostim Revenue Market Share by Countries in 2019
Figure 48. Brazil Romiplostim Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Romiplostim Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Romiplostim Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Romiplostim Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Romiplostim Revenue and Growth Rate (2015-2020)
Figure 53. UAE Romiplostim Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Romiplostim Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Romiplostim Revenue and Growth Rate (2015-2020)
Figure 56. Global Romiplostim Revenue Share by Type (2015-2020)
Figure 57. Global Romiplostim Revenue Share by Type in 2019
Figure 58. Global Romiplostim Market Share Forecast by Type (2021-2025)
Figure 59. Global 250 μg/0.5 mL Revenue Growth Rate (2015-2020)
Figure 60. Global 500 μg/1 mL Revenue Growth Rate (2015-2020)
Figure 61. Global Romiplostim Revenue Share by Application (2015-2020)
Figure 62. Global Romiplostim Revenue Share by Application in 2019
Figure 63. Global Romiplostim Market Share Forecast by Application (2021-2025)
Figure 64. Global Adults Revenue Growth Rate (2015-2020)
Figure 65. Global Pediatric patients Revenue Growth Rate (2015-2020)
Figure 66. Global Romiplostim Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Romiplostim Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Romiplostim Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Romiplostim Revenue Market Forecast (2021-2025)
Figure 70. Europe Romiplostim Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Romiplostim Revenue Market Forecast (2021-2025)
Figure 72. South America Romiplostim Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Romiplostim Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---